$LFLY
Leafly Holdings, Inc. /DE

2022 Q1 Form 10-Q Financial Statement

#000162828022014549 Filed on May 16, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1
Revenue $11.42M $9.475M
YoY Change 20.53%
Cost Of Revenue $1.455M $1.090M
YoY Change 33.49%
Gross Profit $9.965M $8.385M
YoY Change 18.84%
Gross Profit Margin 87.26% 88.5%
Selling, General & Admin $13.95M $6.309M
YoY Change 121.03%
% of Gross Profit 139.94% 75.24%
Research & Development $3.465M $3.170M
YoY Change 9.31%
% of Gross Profit 34.77% 37.81%
Depreciation & Amortization $52.00K $80.00K
YoY Change -35.0%
% of Gross Profit 0.52% 0.95%
Operating Expenses $17.41M $9.479M
YoY Change 83.67% 4413.81%
Operating Profit -$7.445M -$1.094M
YoY Change 580.53% 418.66%
Interest Expense -$697.0K $21.50K
YoY Change -3341.86% -96.88%
% of Operating Profit
Other Income/Expense, Net -$837.0K -$16.00K
YoY Change 5131.25%
Pretax Income -$19.38M -$886.0K
YoY Change 2086.89% -285.9%
Income Tax
% Of Pretax Income
Net Earnings -$19.38M -$1.109M
YoY Change 1647.16% -394.69%
Net Earnings / Revenue -169.67% -11.7%
Basic Earnings Per Share -$0.52 -$0.04
Diluted Earnings Per Share -$0.52 -$0.04
COMMON SHARES
Basic Shares Outstanding 37.53M shares 30.90M shares
Diluted Shares Outstanding 37.53M shares 30.90M shares

Balance Sheet

Concept 2022 Q1 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $35.39M $130.6M
YoY Change -72.91% 32553.72%
Cash & Equivalents $35.39M $292.9K
Short-Term Investments $130.3M
Other Short-Term Assets $100.0K $125.4K
YoY Change -20.24% -37.32%
Inventory
Prepaid Expenses
Receivables $3.280M
Other Receivables $0.00
Total Short-Term Assets $83.21M $418.3K
YoY Change 19792.61% -30.28%
LONG-TERM ASSETS
Property, Plant & Equipment $1.035M
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $130.3M
YoY Change -0.29%
Other Assets
YoY Change
Total Long-Term Assets $1.035M $130.3M
YoY Change -99.21% -0.29%
TOTAL ASSETS
Total Short-Term Assets $83.21M $418.3K
Total Long-Term Assets $1.035M $130.3M
Total Assets $84.25M $130.7M
YoY Change -35.56% -0.43%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.875M $110.7K
YoY Change 2497.11%
Accrued Expenses $3.898M
YoY Change
Deferred Revenue $2.566M $2.023M
YoY Change 26.84%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $16.79M $133.4K
YoY Change 12488.75% -33.31%
LONG-TERM LIABILITIES
Long-Term Debt $28.46M $0.00
YoY Change
Other Long-Term Liabilities $54.03M $4.661M
YoY Change 1059.1%
Total Long-Term Liabilities $82.49M $4.661M
YoY Change 1669.67%
TOTAL LIABILITIES
Total Short-Term Liabilities $16.79M $133.4K
Total Long-Term Liabilities $82.49M $4.661M
Total Liabilities $99.28M $4.795M
YoY Change 1970.45% 2297.59%
SHAREHOLDERS EQUITY
Retained Earnings -$89.15M -$1.454M
YoY Change 6031.37%
Common Stock $4.000K $430.00
YoY Change 830.23%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$15.04M $1.181M
YoY Change
Total Liabilities & Shareholders Equity $84.25M $130.7M
YoY Change -35.56% -0.43%

Cashflow Statement

Concept 2022 Q1 2021 Q1
OPERATING ACTIVITIES
Net Income -$19.38M -$1.109M
YoY Change 1647.16% -394.69%
Depreciation, Depletion And Amortization $52.00K $80.00K
YoY Change -35.0%
Cash From Operating Activities -$14.01M -$368.0K
YoY Change 3705.71% 10.83%
INVESTING ACTIVITIES
Capital Expenditures -$788.0K
YoY Change
Acquisitions
YoY Change
Other Investing Activities $380.6K
YoY Change 11.94%
Cash From Investing Activities -$788.0K $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $58.71M -$25.00K
YoY Change -234944.0%
NET CHANGE
Cash From Operating Activities -$14.01M -$368.0K
Cash From Investing Activities -$788.0K $0.00
Cash From Financing Activities $58.71M -$25.00K
Net Change In Cash $43.92M -$393.0K
YoY Change -11275.06% -7640.29%
FREE CASH FLOW
Cash From Operating Activities -$14.01M -$368.0K
Capital Expenditures -$788.0K
Free Cash Flow -$13.22M
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.52
CY2022Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001785592
CY2022Q1 dei Entity Registrant Name
EntityRegistrantName
Leafly Holdings, Inc. /DE
CY2022Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q1 dei Amendment Flag
AmendmentFlag
false
CY2022Q1 dei Document Type
DocumentType
10-Q
CY2022Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q1 dei Entity File Number
EntityFileNumber
001-39119
CY2022Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
84-2266022
CY2022Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
111 South Jackson Street, Suite 531
CY2022Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Seattle
CY2022Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
WA
CY2022Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
98104
CY2022Q1 dei City Area Code
CityAreaCode
206
CY2022Q1 dei Local Phone Number
LocalPhoneNumber
455-9504
CY2022Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2022Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022Q1 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
42923932 shares
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
35389000 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
28565000 USD
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
2875000 USD
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1682000 USD
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1848000 USD
CY2022Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3280000 USD
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2958000 USD
CY2022Q1 us-gaap Deferred Costs Current
DeferredCostsCurrent
0 USD
CY2021Q4 us-gaap Deferred Costs Current
DeferredCostsCurrent
2840000 USD
CY2022Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7318000 USD
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1347000 USD
CY2022Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
37224000 USD
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
130000 USD
CY2022Q1 us-gaap Assets Current
AssetsCurrent
83211000 USD
CY2021Q4 us-gaap Assets Current
AssetsCurrent
35840000 USD
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1035000 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
313000 USD
CY2022Q1 us-gaap Assets
Assets
84246000 USD
CY2021Q4 us-gaap Assets
Assets
36153000 USD
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3048000 USD
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3898000 USD
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
8325000 USD
CY2022Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2566000 USD
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1975000 USD
CY2022Q1 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
0 USD
CY2021Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
31377000 USD
CY2022Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
7452000 USD
CY2021Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
0 USD
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
16791000 USD
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
44725000 USD
CY2022Q1 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
28461000 USD
CY2021Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
0 USD
CY2022Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
82491000 USD
CY2021Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
0 USD
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
6578000 shares
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
6140000 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
6140000 shares
CY2022Q1 us-gaap Preferred Stock Liquidation Preference Value
PreferredStockLiquidationPreferenceValue
0 USD
CY2021Q4 us-gaap Preferred Stock Liquidation Preference Value
PreferredStockLiquidationPreferenceValue
19436000 USD
CY2022Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
1000 USD
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
84246000 USD
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
69361000 shares
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
42961000 shares
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
42961000 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25086000 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25086000 shares
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
4000 USD
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
3000 USD
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
74106000 USD
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
61194000 USD
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-89146000 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-69770000 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-15036000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-8572000 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
36153000 USD
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11420000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9475000 USD
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
1455000 USD
CY2021Q1 us-gaap Cost Of Revenue
CostOfRevenue
1090000 USD
CY2022Q1 us-gaap Gross Profit
GrossProfit
9965000 USD
CY2021Q1 us-gaap Gross Profit
GrossProfit
8385000 USD
CY2022Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
7014000 USD
CY2021Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3803000 USD
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3465000 USD
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3170000 USD
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6931000 USD
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2506000 USD
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
17410000 USD
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
9479000 USD
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-7445000 USD
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1094000 USD
CY2022Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-697000 USD
CY2021Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
1000 USD
CY2022Q1 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-10397000 USD
CY2021Q1 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
0 USD
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-837000 USD
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-16000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-19376000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-1109000 USD
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.52
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.52
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37525000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37525000 shares
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30904000 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30904000 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-8572000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-19376000 USD
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1924000 USD
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
127000 USD
CY2022Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
0 USD
CY2022Q1 lfly Stock Issued During Period Value Reverse Recapitalization
StockIssuedDuringPeriodValueReverseRecapitalization
27997000 USD
CY2022Q1 lfly Adjustments To Additional Paid In Capital Stockholder Contribution Of Debt Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockholderContributionOfDebtIssuanceCosts
924000 USD
CY2022Q1 lfly Reverse Recapitalization Contingent Consideration Value
ReverseRecapitalizationContingentConsiderationValue
-6867000 USD
CY2022Q1 lfly Adjustments To Additional Paid In Capital Issuance Of Warrant Derivative Liability
AdjustmentsToAdditionalPaidInCapitalIssuanceOfWarrantDerivativeLiability
-3916000 USD
CY2022Q1 lfly Reverse Recapitalization Forward Share Purchase Agreement Value
ReverseRecapitalizationForwardSharePurchaseAgreementValue
-14170000 USD
CY2022Q1 lfly Adjustments To Additional Paid In Capital Contingent Consideration Shareholder Earnout Rights
AdjustmentsToAdditionalPaidInCapitalContingentConsiderationShareholderEarnoutRights
-26131000 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-15036000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
2069000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-1109000 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
181000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
40000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
1181000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-19376000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-1109000 USD
CY2022Q1 us-gaap Depreciation
Depreciation
52000 USD
CY2021Q1 us-gaap Depreciation
Depreciation
80000 USD
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1924000 USD
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
181000 USD
CY2022Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-124000 USD
CY2021Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
82000 USD
CY2022Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
0 USD
CY2021Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
230000 USD
CY2022Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
104000 USD
CY2021Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
0 USD
CY2022Q1 us-gaap Paid In Kind Interest
PaidInKindInterest
243000 USD
CY2021Q1 us-gaap Paid In Kind Interest
PaidInKindInterest
0 USD
CY2022Q1 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-10397000 USD
CY2021Q1 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
0 USD
CY2022Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-12000 USD
CY2021Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-30000 USD
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
198000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
502000 USD
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
5970000 USD
CY2021Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
0 USD
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1309000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-594000 USD
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-2969000 USD
CY2021Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
796000 USD
CY2022Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
591000 USD
CY2021Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
438000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-14005000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-368000 USD
CY2022Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
788000 USD
CY2021Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
0 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-788000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 USD
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
127000 USD
CY2021Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
40000 USD
CY2022Q1 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
29374000 USD
CY2021Q1 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 USD
CY2022Q1 lfly Cash Received From Reverse Recapitalization Net
CashReceivedFromReverseRecapitalizationNet
582000 USD
CY2021Q1 lfly Cash Received From Reverse Recapitalization Net
CashReceivedFromReverseRecapitalizationNet
0 USD
CY2022Q1 us-gaap Proceeds From Derivative Instrument Financing Activities
ProceedsFromDerivativeInstrumentFinancingActivities
39032000 USD
CY2021Q1 us-gaap Proceeds From Derivative Instrument Financing Activities
ProceedsFromDerivativeInstrumentFinancingActivities
0 USD
CY2022Q1 lfly Payments Of Reverse Recapitalization Transaction Costs
PaymentsOfReverseRecapitalizationTransactionCosts
10397000 USD
CY2021Q1 lfly Payments Of Reverse Recapitalization Transaction Costs
PaymentsOfReverseRecapitalizationTransactionCosts
0 USD
CY2022Q1 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
7000 USD
CY2021Q1 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
65000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
58711000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-25000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
43918000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-393000 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
28695000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4934000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
72613000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4541000 USD
CY2022Q1 lfly Stockholder Contribution For Debt Issuance Costs
StockholderContributionForDebtIssuanceCosts
924000 USD
CY2021Q1 lfly Stockholder Contribution For Debt Issuance Costs
StockholderContributionForDebtIssuanceCosts
0 USD
CY2022Q1 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
33024000 USD
CY2021Q1 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
0 USD
CY2022Q1 lfly Forward Share Purchase Agreements Issued
ForwardSharePurchaseAgreementsIssued
14170000 USD
CY2021Q1 lfly Forward Share Purchase Agreements Issued
ForwardSharePurchaseAgreementsIssued
0 USD
CY2022Q1 lfly Warrants Issued
WarrantsIssued
3916000 USD
CY2021Q1 lfly Warrants Issued
WarrantsIssued
0 USD
CY2022Q1 lfly Contingent Consideration Shares Issued
ContingentConsiderationSharesIssued
6867000 USD
CY2021Q1 lfly Contingent Consideration Shares Issued
ContingentConsiderationSharesIssued
0 USD
CY2022Q1 lfly Stockholder Earnout Rights Shares Issued
StockholderEarnoutRightsSharesIssued
26131000 USD
CY2021Q1 lfly Stockholder Earnout Rights Shares Issued
StockholderEarnoutRightsSharesIssued
0 USD
CY2022Q1 lfly Cash Received From Reverse Recapitalization Net
CashReceivedFromReverseRecapitalizationNet
582000 USD
CY2022Q1 lfly Stock Converted Reverse Recapitalization
StockConvertedReverseRecapitalization
35434000 shares
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
42924000 shares
CY2022Q1 us-gaap Use Of Estimates
UseOfEstimates
These condensed consolidated financial statements are unaudited and, in management's opinion, include all adjustments, consisting of normal recurring estimates and accruals necessary for a fair presentation of our consolidated cash flows, operating results, and balance sheets for the periods presented. Actual results may differ from these estimates and assumptions.
CY2022Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
Certain prior period amounts have been reclassified to conform to the current period presentation. These reclassifications had no effect on the reported net loss.
CY2022Q1 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
2159000 USD
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
35389000 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
28565000 USD
CY2022Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
37224000 USD
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
130000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
72613000 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
28695000 USD
CY2022Q1 us-gaap Prepaid Insurance
PrepaidInsurance
5059000 USD
CY2021Q4 us-gaap Prepaid Insurance
PrepaidInsurance
57000 USD
CY2021Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
1134000 USD
CY2022Q1 us-gaap Other Assets Current
OtherAssetsCurrent
100000 USD
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
156000 USD
CY2022Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7318000 USD
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1347000 USD
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1848000 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1131000 USD
CY2022Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-124000 USD
CY2021Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
82000 USD
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
42000 USD
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
272000 USD
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1682000 USD
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
941000 USD
CY2022Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1626000 USD
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1051000 USD
CY2022Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
591000 USD
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
738000 USD
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1035000 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
313000 USD
CY2022Q1 us-gaap Depreciation
Depreciation
52000 USD
CY2021Q1 us-gaap Depreciation
Depreciation
80000 USD
CY2021Q1 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
0 USD
CY2022Q1 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
0 USD
CY2022Q1 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
776000 USD
CY2021Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
3668000 USD
CY2022Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1573000 USD
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2131000 USD
CY2022Q1 us-gaap Interest Payable Current
InterestPayableCurrent
360000 USD
CY2021Q4 us-gaap Interest Payable Current
InterestPayableCurrent
1313000 USD
CY2022Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1189000 USD
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1213000 USD
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3898000 USD
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
8325000 USD
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11420000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9475000 USD
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11420000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9475000 USD
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11420000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9475000 USD
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1975000 USD
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1585000 USD
CY2022Q1 lfly Contract With Customer Liability Increase Decrease
ContractWithCustomerLiabilityIncreaseDecrease
2184000 USD
CY2021Q1 lfly Contract With Customer Liability Increase Decrease
ContractWithCustomerLiabilityIncreaseDecrease
1649000 USD
CY2022Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
1593000 USD
CY2021Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
1211000 USD
CY2022Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2566000 USD
CY2021Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2023000 USD
CY2022Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
CY2022Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0 USD
CY2021Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0 USD
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2021Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q1 lfly Common Stock Voting Rights Number Of Votes
CommonStockVotingRightsNumberOfVotes
1 vote
CY2022Q1 lfly Board Of Directors Number Of Classes
BoardOfDirectorsNumberOfClasses
3 class
CY2022Q1 lfly Board Of Directors Term
BoardOfDirectorsTerm
P3Y
CY2022Q1 lfly Board Of Directors Term
BoardOfDirectorsTerm
P3Y
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q1 lfly Derivative Instrument Number Of Forward Share Purchase Agreements
DerivativeInstrumentNumberOfForwardSharePurchaseAgreements
4 agreement
CY2022Q1 lfly Derivative Instrument Forward Share Purchase Agreement Number Of Shares
DerivativeInstrumentForwardSharePurchaseAgreementNumberOfShares
4000000 shares
CY2022Q1 lfly Derivative Instrument Forward Share Purchase Agreement Term
DerivativeInstrumentForwardSharePurchaseAgreementTerm
P3M
CY2022Q1 lfly Share Based Compensation Arrangement By Share Based Payment Award Number Of Plans
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans
4 plan
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3851000 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.77
CY2022Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
114000 shares
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.12
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
56000 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
1.08
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3681000 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.78
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
23918000 USD
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y7M13D
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1339000 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.98
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
9770000 USD
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P7Y11M23D
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1924000 USD
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
181000 USD
CY2022Q1 lfly Share Based Compensation Arrangement By Share Based Payment Award Options Modified
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsModified
2917000 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Incremental Compensation Cost
ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost
1366000 USD
CY2022Q1 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
244000 USD
CY2021Q1 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
151000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-19376000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-1109000 USD
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37525000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37525000 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30904000 shares
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30904000 shares
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.52
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
23586000 shares
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7967000 shares
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11420000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9475000 USD
CY2022Q1 us-gaap Gross Profit
GrossProfit
9965000 USD
CY2021Q1 us-gaap Gross Profit
GrossProfit
8385000 USD

Files In Submission

Name View Source Status
0001628280-22-014549-index-headers.html Edgar Link pending
0001628280-22-014549-index.html Edgar Link pending
0001628280-22-014549.txt Edgar Link pending
0001628280-22-014549-xbrl.zip Edgar Link pending
a311seccertificationceo.htm Edgar Link pending
a312sec302certificationcfo.htm Edgar Link pending
a32sec906certification.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
lfly-20220331.htm Edgar Link pending
lfly-20220331.xsd Edgar Link pending
lfly-20220331_cal.xml Edgar Link unprocessable
lfly-20220331_def.xml Edgar Link unprocessable
lfly-20220331_htm.xml Edgar Link completed
lfly-20220331_lab.xml Edgar Link unprocessable
lfly-20220331_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending